Search hospitals > Maryland > Baltimore
Kennedy Krieger Institute
Claim this profileBaltimore, Maryland 21205
Global Leader in Muscular Dystrophy
Global Leader in Autism Spectrum Disorder
Conducts research for Autism
Conducts research for Syndrome
Conducts research for Duchenne Muscular Dystrophy
146 reported clinical trials
10 medical researchers
Summary
Kennedy Krieger Institute is a medical facility located in Baltimore, Maryland. This center is recognized for care of Muscular Dystrophy, Autism Spectrum Disorder, Autism, Syndrome, Duchenne Muscular Dystrophy and other specialties. Kennedy Krieger Institute is involved with conducting 146 clinical trials across 184 conditions. There are 10 research doctors associated with this hospital, such as Doris Leung, MD, Dejan Budimirovic, MD, Genila Bibat, MD, and Stacy Suskauer, MD.Area of expertise
1Muscular Dystrophy
Global LeaderFKRP positive
dystrophin positive
SMCHD1 mutation positive
2Autism Spectrum Disorder
Global LeaderTop PIs
Doris Leung, MDKennedy Krieger Institute1 year of reported clinical research
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
9 reported clinical trials
10 drugs studied
Dejan Budimirovic, MDKennedy Krieger Institute2 years of reported clinical research
Studies Fragile X Syndrome
Studies Syndrome
4 reported clinical trials
8 drugs studied
Genila Bibat, MDKennedy Krieger Institute3 years of reported clinical research
Studies Muscular Dystrophy
Studies Excessive Daytime Sleepiness
4 reported clinical trials
5 drugs studied
Stacy Suskauer, MDKennedy Krieger Institute2 years of reported clinical research
Studies Traumatic Brain Injury
Studies Wounds and Injuries
2 reported clinical trials
3 drugs studied
Clinical Trials running at Kennedy Krieger Institute
Limb-Girdle Muscular Dystrophy
Muscular Dystrophy
Duchenne Muscular Dystrophy
Autism
Syndrome
Attention Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder
Fragile X Syndrome
Adrenoleukodystrophy
Traumatic Brain Injury
Ribitol
for Limb-Girdle Muscular Dystrophy
This study will evaluate the safety and efficacy of long-term administration of BBP-418 in patients with LGMD2I/R9. The study will include patients ages 12 to 60, consistent with the existing preclinical toxicology profile. This will encompass the significant majority of existing diagnosed patients based upon the established epidemiology of the disease.
Recruiting1 award Phase 36 criteria
LION-101
for Limb-Girdle Muscular Dystrophy
The purpose of this study is to evaluate the safety and tolerability of a single intravenous infusion of AB-1003 in adults diagnosed with limb girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). Participants will be treated in sequential, dose-level cohorts. (Part 1)
Recruiting0 awards Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kennedy Krieger Institute?
Kennedy Krieger Institute is a medical facility located in Baltimore, Maryland. This center is recognized for care of Muscular Dystrophy, Autism Spectrum Disorder, Autism, Syndrome, Duchenne Muscular Dystrophy and other specialties. Kennedy Krieger Institute is involved with conducting 146 clinical trials across 184 conditions. There are 10 research doctors associated with this hospital, such as Doris Leung, MD, Dejan Budimirovic, MD, Genila Bibat, MD, and Stacy Suskauer, MD.